FundingWatcher
Home / Startups / Top health care startups / Health care startups that raised Series C / Health care startups that raised Series C in Europe

Health care startups that raised Series C in Europe

Updated 16 Nov 2026

Reset
Health care startups that raised Series C in Europe
One-time CSV
  • 137 funded companies, 95 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care--series-c~europe.csv137 rows × 18 columns
CompanyCityLast roundAmountDate
MicrobioticaCambridgeSeries C$47.9M2026-10-16
Basecamp ResearchLondonSeries C$140.0M2026-09-23
SembleLondonSeries C$40.3M2026-06-04
FreshaLondonSeries C$80.0M2026-05-21
ADCendoCopenhagenSeries C$75.0M2026-04-14
BrainomixOxfordSeries C$6.5M2026-02-24
NucleraCambridgeSeries C$12.0M2026-01-13
KatKinLondonSeries C$50.0M2025-12-13

8 rows of the CSV in 5 of its 18 columns.

137
Startups
$9.5B
Total raised
14
Funded in the last 12 months
$1.6B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 137
30 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
Microbiotica Microbiotica develops live bacterial microbiome therapeutics and associated biomarkers. Biotech Cambridge, United Kingdom Series C $47.9M 2026-10-16 $130.7M Seventure Partners, IP Group, Cambridge Innovation Capital +1 11 to 50 2016
Basecamp Research Basecamp Research is a biotechnology company that uses AI and biological data to develop therapeutics. Artificial intelligence London, United Kingdom Series C $140.0M 2026-09-23 $219.9M True Ventures, redalpine, Hummingbird Ventures +1 51 to 100 2019
Semble Semble develops practice management and health record software for private healthcare providers. Health care London, United Kingdom Series C $40.3M 2026-06-04 $67.2M Octopus Ventures, Salica, Triple Point Ventures +2 101 to 250 2017
Fresha Fresha is a marketplace platform that helps users find nearby beauty, wellness, and self-care services. Commerce London, United Kingdom Series C $80.0M 2026-05-21 $299.0M FJ Labs, Partech, Target Global +2 251 to 500 2015
ADCendo ADCendo develops antibody-drug conjugates to target cancers with high unmet medical needs. Biotech Copenhagen, Denmark Series C $75.0M 2026-04-14 $324.6M RA Capital Management, Novo Holdings, Gilde Healthcare +2 51 to 100 2017
Brainomix Brainomix creates AI-powered imaging biomarkers that support precision medicine treatment decisions. Artificial intelligence Oxford, United Kingdom Series C $6.5M 2026-02-24 $60.2M Innovate UK, Parkwalk Advisors, Boehringer Ingelheim Venture Fund +1 51 to 100 2010
Nuclera Nuclera provides a protein prototyping system that makes proteins readily available to drug discovery researchers. Biotech Cambridge, United Kingdom Series C $12.0M 2026-01-13 $157.8M Innovate UK, Verve Ventures, Amadeus Capital Partners +2 101 to 250 2013
KatKin KatKin produces healthy cat food that supports digestion, shiny coats, and energy. Commerce London, United Kingdom Series C $50.0M 2025-12-13 $79.0M Octopus Ventures, Redbus Ventures, Verlinvest +2 101 to 250 2019
4TEEN4 Pharmaceuticals 4TEEN4 Pharmaceuticals develops therapies and biomarkers for diagnosing, predicting, and treating circulatory shock. Biotech Hennigsdorf, Germany Series C $36.1M 2025-11-13 $95.9M Wellington Partners, Brandenburg Kapital, HBM Healthcare Investments +1 11 to 50 2013
Tubulis Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications. Biotech Munich, Germany Series C $400.6M 2025-10-15 $616.9M HTGF (High-Tech Gruenderfonds), Bayern Kapital, Seventure Partners +1 51 to 100 2012
Cutiss Cutiss is a life science company that produces regenerative medicine and engineers skin tissue. Biotech Zürich, Switzerland Series C $38.8M 2025-09-10 $94.6M Innosuisse 11 to 50 2017
Nabla Nabla provides AI tools that generate real-time clinical notes to support clinicians. Artificial intelligence Paris, France Series C $70.0M 2025-06-17 $114.6M Cathay Innovation, ZEBOX Ventures 101 to 250 2018
ENYO Pharma ENYO Pharma is a biopharmaceutical company based in Lyon, France. Biotech Lyon, France Series C $7.0M 2025-06-12 $108.8M Bpifrance, OrbiMed, Sofinnova Partners +2 11 to 50 2014
ImmunOs Therapeutics ImmunOs Therapeutics is a clinical-stage biotechnology company. Biotech Schlieren, Switzerland Series C $11.0M 2024-09-17 Lightspeed Venture Partners, Innosuisse, Mission BioCapital +1 11 to 50 2014
Asceneuron Asceneuron develops therapeutics for orphan tauopathies and Alzheimer's disease. Biotech Lausanne, Switzerland Series C $100.0M 2024-07-16 OrbiMed, Novo Holdings, EQT Life Sciences +1 1 to 10 2012
Firstvet FirstVet is a digital veterinary platform that provides video consultations for pet owners. Health care Stockholm, Sweden Series C $21.5M 2024-06-24 $83.4M Creandum, OMERS Ventures, Cathay Innovation +2 101 to 250 2016
Memo Therapeutics Memo Therapeutics conducts biotechnology research in antibody discovery and immune repertoire analysis. Biotech Schlieren, Switzerland Series C $22.0M 2024-05-07 $108.8M Verve Ventures, Kurma Partners, Pureos Bioventures +1 11 to 50 2012
Onera Health Onera Health provides sleep diagnostics and monitoring products for clinical and home use. Hardware Eindhoven, The Netherlands Series C $32.6M 2024-01-16 $57.0M European Innovation Council, EQT Life Sciences, Gimv +1 11 to 50 2017
Genomics Genomics plc works to bring genomic medicine into healthcare. Biotech Oxford, United Kingdom Series C $44.6M 2024-01-08 $135.4M Innovate UK, IP Group, Oxford Science Enterprises +1 101 to 250 2014
Apollo Therapeutics Apollo Therapeutics develops medicines by translating medical research into biopharmaceutical portfolios. Biotech Cambridge, United Kingdom Series C $33.5M 2024-01-02 $397.9M UCL Technology Fund, Patient Square Capital, Rock Springs Capital 51 to 100 2016
Pai Skincare Pai Skincare sells premium products designed for sensitive skin of all types. Commerce London, United Kingdom Series C $17.4M 2023-04-11 Famillie C (Clarins Family), Famille C Participations 11 to 50 2007
NBE-Therapeutics NBE-Therapeutics develops oncology treatments for cancer patients. Biotech Basel, Switzerland Series C $22.0M 2020-01-10 $65.7M Novo Holdings, Boehringer Ingelheim Venture Fund, PPF Group 11 to 50 2012
dacadoo dacadoo offers digital lifestyle solutions through mobile apps from its base in Switzerland. Biotech Zürich, Switzerland Series C $71.1M 2019-12-13 Samsung Ventures 51 to 100 2010
Endosense Endosense develops medical technology that improves the reproducibility of catheter ablation for cardiac arrhythmias. Biotech Geneva, Switzerland Series C $41.2M 2013-11-27 3i Group, VI Partners, Andera Partners +2 51 to 100 2003
Viroblock Viroblock is a Swiss company developing antiviral technology for air filtration products. Biotech Geneva, Switzerland Series C $4.5M 2012-02-14 $4.5M StartAngels Network, BlueOcean Ventures 1 to 10 2005
GILUPI GILUPI develops medical devices that isolate rare cells from circulating blood in vivo. Biotech Potsdam, Germany Series C $4.8M 2011-01-13 $4.8M HTGF (High-Tech Gruenderfonds), KfW, Brandenburg Kapital +1 11 to 50 2005
MTM Laboratories MTM Laboratories manufactures in-vitro diagnostic tests for detecting and diagnosing cervical and other cancers early. Biotech Heidelberg, Germany Series C $9.7M 2010-11-08 $109.7M Wellington Partners, LBBW VC, Gilde Healthcare +2 1,001 to 5,000 1999
Synosia Therapeutics Synosia Therapeutics develops and commercializes products for unmet needs in psychiatry and neurology. Biotech Basel, Switzerland Series C $30.0M 2010-10-12 $94.0M Novo Holdings, Versant Ventures, 5AM Ventures +2 1 to 10 2006
CMOSIS nv CMOSIS nv designs and supplies standard and custom CMOS image sensors for professional, scientific, and industrial uses. Biotech Antwerp, Belgium Series C $4.2M 2009-08-10 Capital-E, Vinnof 51 to 100 2007
Signature Diagnostics GmbH Signature Diagnostics GmbH develops translational oncology and genomics tests for cancer care. Biotech Potsdam, Germany Series C $7.6M 2008-08-12 KfW, BFB Fruehphasenfonds, EVP Capital Management +1 1 to 10 2004

Table 1. Health care startups that raised Series C in Europe: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 137.

Largest rounds

Last 12 months
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 Basecamp Research Basecamp Research is a biotechnology company that uses AI and biological data to develop therapeutics. Artificial intelligence London, United Kingdom Series C $140.0M 2026-09-23 $219.9M True Ventures, redalpine, Hummingbird Ventures +1 51 to 100 2019
2 Fresha Fresha is a marketplace platform that helps users find nearby beauty, wellness, and self-care services. Commerce London, United Kingdom Series C $80.0M 2026-05-21 $299.0M FJ Labs, Partech, Target Global +2 251 to 500 2015
3 ADCendo ADCendo develops antibody-drug conjugates to target cancers with high unmet medical needs. Biotech Copenhagen, Denmark Series C $75.0M 2026-04-14 $324.6M RA Capital Management, Novo Holdings, Gilde Healthcare +2 51 to 100 2017
4 KatKin KatKin produces healthy cat food that supports digestion, shiny coats, and energy. Commerce London, United Kingdom Series C $50.0M 2025-12-13 $79.0M Octopus Ventures, Redbus Ventures, Verlinvest +2 101 to 250 2019
5 Microbiotica Microbiotica develops live bacterial microbiome therapeutics and associated biomarkers. Biotech Cambridge, United Kingdom Series C $47.9M 2026-10-16 $130.7M Seventure Partners, IP Group, Cambridge Innovation Capital +1 11 to 50 2016
6 Semble Semble develops practice management and health record software for private healthcare providers. Health care London, United Kingdom Series C $40.3M 2026-06-04 $67.2M Octopus Ventures, Salica, Triple Point Ventures +2 101 to 250 2017
7 Nuclera Nuclera provides a protein prototyping system that makes proteins readily available to drug discovery researchers. Biotech Cambridge, United Kingdom Series C $12.0M 2026-01-13 $157.8M Innovate UK, Verve Ventures, Amadeus Capital Partners +2 101 to 250 2013
8 Brainomix Brainomix creates AI-powered imaging biomarkers that support precision medicine treatment decisions. Artificial intelligence Oxford, United Kingdom Series C $6.5M 2026-02-24 $60.2M Innovate UK, Parkwalk Advisors, Boehringer Ingelheim Venture Fund +1 51 to 100 2010

Table 2. Health care startups that raised Series C in Europe: the 8 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 KfW Government investment office Frankfurt, Germany 7 5%
2 HTGF (High-Tech Gruenderfonds) Venture capital firm Bonn, Germany 6 4% 1 CereGate
3 Novo Holdings Corporate venture arm Hellerup, Denmark 4 3% 1 ADCendo
4 Innovate UK Entrepreneurship program Swindon, United Kingdom 4 3% 2 Brainomix, Nuclera
5 Andera Partners Private equity firm Paris, France 4 3%
6 Seventure Partners Venture capital firm Paris, France 3 2% 1 Microbiotica
7 Wellington Partners Venture capital firm Munich, Germany 3 2%
8 EQT Life Sciences Private equity firm Amsterdam, The Netherlands 3 2%
9 IP Group Venture capital firm London, United Kingdom 2 1% 1 Microbiotica
10 Octopus Ventures Venture capital firm London, United Kingdom 2 1% 2 Semble, KatKin
11 Partech Venture capital firm Paris, France 2 1% 1 Fresha
12 Gilde Healthcare Private equity firm Utrecht, The Netherlands 2 1% 1 ADCendo
13 RA Capital Management Startup incubator Boston, United States 2 1% 1 ADCendo
14 HealthCap Venture capital firm Stockholm, Sweden 2 1% 1 ADCendo
15 Parkwalk Advisors Venture capital firm London, United Kingdom 2 1% 1 Brainomix

Table 3. Health care startups that raised Series C in Europe: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 93 68% $6.6B
Software 24 18% $2.4B
Artificial intelligence 7 5% $1.4B
Hardware 6 4% $57.0M
Commerce 5 4% $378.0M
Fintech 2 1% $50.0M
Education 1 1% $81.2M

Table 4. Health care startups that raised Series C in Europe by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series C 137 100% $25.0M

Table 5. Health care startups that raised Series C in Europe by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
United Kingdom 43 31%
Germany 23 17%
Switzerland 19 14%
France 18 13%
The Netherlands 7 5%
Spain 6 4%
Sweden 5 4%
Denmark 4 3%
Belgium 4 3%
Ireland 2 1%
Italy 2 1%
Portugal 1 1%

Table 6. Health care startups that raised Series C in Europe by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
London 13 9%
Cambridge 9 7%
Paris 7 5%
Berlin 7 5%
Oxford 6 4%
Munich 5 4%
Stockholm 4 3%
Barcelona 3 2%
Basel 3 2%
Geneva 3 2%
Copenhagen 2 1%
Zürich 2 1%

Table 7. Health care startups that raised Series C in Europe by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 3 21% $357.9M
September 2026 2 14% $196.0M
July 2026 2 14% $737.7M
June 2026 1 7% $40.3M
May 2026 1 7% $80.0M
April 2026 2 14% $131.0M
February 2026 1 7% $6.5M
January 2026 1 7% $12.0M
December 2025 1 7% $50.0M

Table 8. Health care startups that raised Series C in Europe: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 13 9% $1.6B
2025 12 9% $901.1M
2024 12 9% $455.0M
2023 9 7% $343.1M
2022 4 3% $193.2M
2021 12 9% $529.5M

Table 9. Health care startups that raised Series C in Europe by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 2 1%
2015 to 2019 40 29%
2010 to 2014 41 30%
Before 2010 54 39%

Table 10. Health care startups that raised Series C in Europe by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 16 12%
11 to 50 74 54%
51 to 100 24 18%
101 to 250 12 9%
251 to 500 4 3%
501 to 1,000 3 2%
1,001 to 5,000 2 1%
10,001 or more 1 1%

Table 11. Health care startups that raised Series C in Europe by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in Europe whose last round is Series C are on the list?
137, in the file dated 16 November 2026. 14 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 137 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups that raised Series C in Europe: 137 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care at other stages in Europe

Other sectors that raised Series C in Europe

Cite: FundingWatcher, 137 health care companies in Europe whose most recent round is Series C, 16 November 2026. https://fundingwatcher.com/startups/health-care/series-c/europe/